Xiangqian Guo Selected Research

1-(2-hydroxyethyl)-1-nitrosourea (HENU)

1/2020

OSskcm: an online survival analysis webserver for skin cutaneous melanoma based on 1085 transcriptomic profiles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiangqian Guo Research Topics

Disease

32	Neoplasms (Cancer) 02/2022 - 01/2012
5	Carcinogenesis 11/2020 - 02/2017
4	Breast Neoplasms (Breast Cancer) 01/2020 - 02/2009
4	Leiomyosarcoma 09/2017 - 10/2012
4	Sarcoma (Soft Tissue Sarcoma) 06/2014 - 01/2012
3	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 01/2019
3	Carcinoma (Carcinomatosis) 01/2020 - 05/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 02/2022 - 01/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2021 - 01/2020
2	Esophageal Squamous Cell Carcinoma 01/2021 - 01/2019
2	Glioma (Gliomas) 01/2021 - 01/2020
2	Carcinosarcoma 01/2020 - 02/2017
2	Neoplasm Metastasis (Metastasis) 10/2019 - 02/2017
2	Endometrial Stromal Sarcoma 10/2012 - 01/2012
1	cyclic Thrombocytopenia 04/2022
1	Rare Diseases (Rare Disease) 04/2022
1	Squamous Cell Carcinoma of Head and Neck 03/2022
1	Esophageal Neoplasms (Esophageal Cancer) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	COVID-19 11/2020
1	Endometrial Neoplasms (Endometrial Cancer) 03/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2019
1	Adenocarcinoma of Lung 10/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2019
1	CADASIL 09/2019
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Muscular Dystrophies (Muscular Dystrophy) 06/2014

Drug/Important Bio-Agent (IBA)

27	Biomarkers (Surrogate Marker)IBA 03/2022 - 08/2012
8	RNA (Ribonucleic Acid)IBA 03/2022 - 08/2012
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
4	ParaffinIBA 08/2015 - 12/2013
4	Formaldehyde (Formol)FDA Link 08/2015 - 12/2013
2	Biological ProductsIBA 01/2022 - 11/2021
2	Peptides (Polypeptides)IBA 12/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 03/2020 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2019
2	Long Noncoding RNAIBA 05/2014 - 08/2012
1	Cytidine Triphosphate (CTP)IBA 04/2022
1	AnnexinsIBA 02/2022
1	Tripartite Motif ProteinsIBA 11/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	MicropeptidesIBA 01/2021
1	IntegrinsIBA 12/2020
1	Immunodominant EpitopesIBA 12/2020
1	arginyl-glycyl-aspartic acidIBA 12/2020
1	Peptide Hydrolases (Proteases)FDA Link 11/2020
1	Cathepsin LIBA 11/2020
1	Angiotensin-Converting Enzyme 2IBA 11/2020
1	Cathepsin BIBA 11/2020
1	Aurora Kinase AIBA 11/2020
1	Serum AlbuminIBA 03/2020
1	Qa-SNARE Proteins (Syntaxin)IBA 01/2020
1	1-(2-hydroxyethyl)-1-nitrosourea (HENU)IBA 01/2020
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2020
1	eltrombopag FDA Link 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Keratin-8 (Keratin 8)IBA 10/2019
1	DNA (Deoxyribonucleic Acid)IBA 09/2019
1	CytokinesIBA 02/2019
1	Chimeric Antigen ReceptorsIBA 02/2019
1	Syk KinaseIBA 02/2017
1	Cell Cycle ProteinsIBA 02/2017
1	CDX2 Transcription FactorIBA 01/2016
1	Protein Isoforms (Isoforms)IBA 06/2014
1	DystrophinIBA 06/2014
1	Cyclin D1IBA 10/2012
1	CyclinsIBA 10/2012
1	Indicators and Reagents (Reagents)IBA 10/2012
1	Estrogen ReceptorsIBA 08/2012
1	Oncogene Proteins (Oncogene Protein)IBA 01/2012
1	14-3-3 Proteins (14-3-3 Protein)IBA 01/2012
1	Small Untranslated RNAIBA 02/2009

Therapy/Procedure

9	Therapeutics 01/2021 - 06/2014
1	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2019
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2019
1	Drug Therapy (Chemotherapy) 09/2017
1	Adjuvant Chemotherapy 01/2016